Ritchey Matthew, Yuan Keming, Gillespie Cathleen, Zhang Guangyu, Ostchega Yechiam
Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD.
J Clin Hypertens (Greenwich). 2016 Aug;18(8):750-61. doi: 10.1111/jch.12746. Epub 2016 Jan 5.
Health systems are well positioned to identify and control hypertension among their patients. However, almost one third of US adults with uncontrolled hypertension are currently receiving medical care and are unaware of being hypertensive. This study describes the development and validation of a tool that health systems can use to compare their reported hypertension prevalence with their expected prevalence. Tool users provide the number of patients aged 18 to 85 years treated annually, stratified by sex, age group, race/ethnicity, and comorbidity status. Each stratum is multiplied by stratum-specific national prevalence estimates and the amounts are summed to calculate the number of expected hypertensive patients. The tool's validity was assessed by applying samples from cohorts with known hypertension prevalence; small differences in expected vs actual prevalence were identified (range, -3.3% to 0.6%). This tool provides clinically useful hypertension prevalence estimates that health systems can use to help inform hypertension management quality improvement efforts.
卫生系统在识别和控制患者中的高血压方面具有良好的条件。然而,目前美国近三分之一未得到控制的高血压成年患者正在接受医疗护理,但却未意识到自己患有高血压。本研究描述了一种工具的开发和验证过程,卫生系统可利用该工具将其报告的高血压患病率与其预期患病率进行比较。工具使用者提供每年治疗的18至85岁患者数量,并按性别、年龄组、种族/族裔和合并症状态进行分层。每个分层乘以特定分层的全国患病率估计值,然后将这些数值相加,以计算预期高血压患者的数量。通过应用来自已知高血压患病率队列的样本对该工具的有效性进行评估;预期患病率与实际患病率之间存在微小差异(范围为-3.3%至0.6%)。该工具提供了临床上有用的高血压患病率估计值,卫生系统可利用这些估计值为高血压管理质量改进工作提供参考。